Balestracci, B.; Candido, G.; Federici, L.; Parretti, C.; Tartaglia, R.; Lachman, P.; Bianco, A.; La Regina, M.
Anti-COVID-19 Vaccination in the Italian General Population: Proactive Clinical Risk Analysis Using Failure Mode, Effects, and Criticality Analysis Technique. Healthcare 2024, 12, 2541.
https://doi.org/10.3390/healthcare12242541
AMA Style
Balestracci B, Candido G, Federici L, Parretti C, Tartaglia R, Lachman P, Bianco A, La Regina M.
Anti-COVID-19 Vaccination in the Italian General Population: Proactive Clinical Risk Analysis Using Failure Mode, Effects, and Criticality Analysis Technique. Healthcare. 2024; 12(24):2541.
https://doi.org/10.3390/healthcare12242541
Chicago/Turabian Style
Balestracci, Beatrice, Giuseppe Candido, Lorenzo Federici, Chiara Parretti, Riccardo Tartaglia, Peter Lachman, Alessandra Bianco, and Micaela La Regina.
2024. "Anti-COVID-19 Vaccination in the Italian General Population: Proactive Clinical Risk Analysis Using Failure Mode, Effects, and Criticality Analysis Technique" Healthcare 12, no. 24: 2541.
https://doi.org/10.3390/healthcare12242541
APA Style
Balestracci, B., Candido, G., Federici, L., Parretti, C., Tartaglia, R., Lachman, P., Bianco, A., & La Regina, M.
(2024). Anti-COVID-19 Vaccination in the Italian General Population: Proactive Clinical Risk Analysis Using Failure Mode, Effects, and Criticality Analysis Technique. Healthcare, 12(24), 2541.
https://doi.org/10.3390/healthcare12242541
